Literature DB >> 25923102

The quality of life and psychological, social and cognitive functioning of patients with acromegaly.

Dorota Szcześniak1, Aleksandra Jawiarczyk-Przybyłowska2, Joanna Rymaszewska1.   

Abstract

Acromegaly is a rare and chronic disease, most often caused by a pituitary adenoma. Excessive secretion of the growth hormone (GH) leads to hepatic secretion of insulin-like growth factor-1 (IGF-1), which in turn causes characteristic changes in the patient's appearance, many skeletal deformities and metabolic disorders. In addition to somatic symptoms, acromegalic patients demonstrate psychosocial and personality deficits, as well as common co-occurrence of mental disorders. There are few studies investigating acromegaly in Poland. In recent years, the concept of quality of life has become fundamental to understanding health problems. Studies dealing with acromegaly likewise tend to include assessments of quality of life of patients suffering from this endocrinopathy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25923102     DOI: 10.17219/acem/38156

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  8 in total

Review 1.  Biochemical investigations in diagnosis and follow up of acromegaly.

Authors:  Katharina Schilbach; Christian J Strasburger; Martin Bidlingmaier
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

2.  Quality of Life in Patients with Acromegaly - A Romanian Single Center Cross-Sectional Study.

Authors:  C L Scânteie; D C Leucuţa; C M V Ghervan
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

Review 3.  Cognitive-behavioral therapy improves the quality of life of patients with acromegaly.

Authors:  Lia Silvia Kunzler; Luciana Ansaneli Naves; Luiz Augusto Casulari
Journal:  Pituitary       Date:  2018-06       Impact factor: 4.107

Review 4.  Challenges in the diagnosis and management of acromegaly: a focus on comorbidities.

Authors:  Alin Abreu; Alejandro Pinzón Tovar; Rafael Castellanos; Alex Valenzuela; Claudia Milena Gómez Giraldo; Alejandro Castellanos Pinedo; Doly Pantoja Guerrero; Carlos Alfonso Builes Barrera; Humberto Ignacio Franco; Antônio Ribeiro-Oliveira; Lucio Vilar; Raquel S Jallad; Felipe Gaia Duarte; Mônica Gadelha; Cesar Luiz Boguszewski; Julio Abucham; Luciana A Naves; Nina Rosa C Musolino; Maria Estela Justamante de Faria; Ciliana Rossato; Marcello D Bronstein
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

5.  Personality Traits and Physical Complaints in Patients With Acromegaly: A Cross Sectional Multi-Center Study With Analysis of Influencing Factors.

Authors:  Anca Zimmermann; Rüdiger Zwerenz; Michael Droste; Christof Schöfl; Christian J Strasburger; Ursula Plöckinger; Athanasia Ziagaki; Jürgen Honegger; Anne Dixius; Bledar Millaku; Gerrit Toenges; Manfred E Beutel; Matthias M Weber
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-17       Impact factor: 5.555

6.  The Internal Cranial Anatomy of a Female With Endocrine Disorders From a Mediaeval Population.

Authors:  Anna Maria Kubicka; Philippe Charlier; Antoine Balzeau
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-14       Impact factor: 6.055

Review 7.  Need for improved monitoring in patients with acromegaly.

Authors:  Julie M Silverstein
Journal:  Endocr Connect       Date:  2015-09-17       Impact factor: 3.335

8.  Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease.

Authors:  Philip P Ostrowski; Andrew Barszczyk; Julia Forstenpointner; Wenhua Zheng; Zhong-Ping Feng
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.